Editor Biography EditorProf. Dennis McGonagle, University of Leeds, England ConferenceACR 2019 3 February 2020 09:15
Lowest risk of infection after therapy with an IL-12/IL-23 blocker Presented ByDr Yinzhu Jin, Brigham and Women´s Hospital and Harvard Medical School, Boston, USA TrialCohort study ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 23:42
Calcium pyrophosphate deposition disease: an independent risk factor for cardiovascular complications Presented ByDr Maaman Bashir, Medical College of Wisconsin, USA ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 22:45
Proteome abnormalities improve prediction of RA development Presented ByDr Liam O´Neil, University of Manitoba, Canada ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 21:47
RA patients in remission benefit from continued therapy with conventional DMARDs Presented ByDr Siri Lillegraven, Diakonhjemmet Hospital,Norway TrialARCTIC REWIND, TARA ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 20:51
Selective IL-23 blocker shows remarkable efficacy in patients with psoriatic arthritis Presented ByProf. Atul Deodhar, Oregon Health & Science University, USA TrialPhase 3, DISCOVER ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 19:53
Corticosteroid therapy in GCA: higher platelets – lower relapse rate Presented ByDr Samuel Deshayes, Hospital Center University Of Caen Normandie, France ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 09:55
Filgotinib promising in RA patients naïve to methotrexate Presented ByProf. Rene Westhovens, University of Leuven, Belgium TrialPhase 3, FINCH 3 ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 23:05
Sustained efficacy of monotherapy with upadacitinib after 48 weeks Presented ByProf. Joseph Smolen, Medical University of Vienna, Austria TrialSELECT-MONOTHERAPY ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 22:06
Biologics show similar activity in patients with elderly-onset RA Presented ByDr Sadao Jinno, Kobe University School of Medicine, Japan ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 21:08
Tocilizumab outperforms rituximab in RA patients with low level of synovial B cell infiltration Presented ByProf. Costantino Pitzalis, Barts and The London School of Medicine and Dentistry, UK ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 20:10
Treatment decisions should not be guided by ultrasound findings Presented ByDr Espen Haavardsholm, Diakonhjemmet Hospital, Oslo, Norway TrialARCTIC, TaSER ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 19:11
Cancer treatment with checkpoint inhibitors in RA patients? Presented ByDr Sabina Sandigursky, New York University Langone Medical Center, USA ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 11:13
Anifrolumab succeeds in second phase 3 trial in SLE Presented ByProf. Eric Morand, Prof. Richard Furie TrialPhase 3, TULIP ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 23:44
Depression closely related to fatigue in SLE patients Presented ByChristina Düsing, Universitätsklinikum Düsseldorf, Germany ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 12:47
Psoriasis onset determines sequence of symptoms Presented ByProf. Umut Kalyoncu, Hacettepe University, Turkey ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 23:07
Higher psychiatric comorbidity in women with PsA Presented ByProf. Mehmet Duruöz, Marmara University Hospital, Turkey ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 22:50
JAK1 inhibition shows remarkable efficacy in AS Presented ByProf. Désirée van der Heijde, Leiden University Medical Center, the Netherlands TrialPhase 3, SELECT-AXIS 1 ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 20:57
CARDAS study shows increased prevalence of cardiac valvular disorders in AS patients Presented ByMr Milad Baniaamam, Amsterdam University Medical Center, the Netherlands TrialCARDAS ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 10:04
Hand OA: low-dose corticosteroids improve symptoms Presented ByDr Féline Kroon, Prof. Christian Roux TrialHOPE ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 23:07
Opioids: no quality of life benefits for OA patients Presented ByDr Raveendhara Bannuru, Tufts Medical Center, USA ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 22:08
Walking speed is a predictor of mortality in patients with knee OA Presented ByDr Hiral Master, University of Delaware,, USA ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 10:10
Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib Presented ByDr Evelyne Vinet, McGill University, Montreal, Canada ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 23:12
Prevention of congenital heart block may be possible with hydroxychloroquine Presented ByProf. Peter Izmirly, New York University School of Medicine, USA TrialPATCH ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 22:14
TNFi for RA during pregnancy – to stop or not to stop? Presented ByDr Isabell Haase, Heinrich-Heine University Düsseldorf, Germany ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 10:16
Rituximab maintenance superior to azathioprine in ANCA-associated vasculitis Presented ByDr Rona Smith, University of Cambridge, UK TrialRITAZAREM ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 23:18
Prolonged remission after stop of tocilizumab for patients with giant cell arteritis Presented ByProf. John H. Stone, Harvard Medical School, Boston, USA TrialPhase 3, GiACTA ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 10:19
Antifibrotic therapy slows disease progression independent of corticosteroid use Presented ByDr Madelon Vonk, Radboud University, the Netherlands TrialSENSCIS ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 23:22
Fibromyalgia patients often experienced abuse in childhood Presented ByDr Carmen Gota, Cleveland Clinic, Ohio, USA ConferenceACR 2019 TypePeer-reviewed article 4 February 2020 10:23